The platform, termed High-Throughput Elicitor Screening (HiTES), features a proprietary, patented high-throughput technology for activation of silent microbial genes as well as an in-house bacterial culture collection and lead-prioritization software. Together, these technologies enable discovery of natural products that cannot be accessed by other approaches. They will be used to generate high-value molecules for further development and for out-licensing.